From the Journals

Reported penicillin allergies hike inpatient costs


 

FROM JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE

Total inpatient costs for patients who report being allergic to penicillin are much higher than for those who don’t report an allergy, according to a recent systematic review and meta-analysis.

The review, which eventually included 30 articles, found that total inpatient costs ranged from an average $1,145-$4,254 higher per patient with a reported penicillin allergy compared to nonallergic patients, said T. Joseph Mattingly, PharmD, and his associates. Outpatient prescription costs were also estimated to be steeper, running $14-$93 higher per patient who reported a penicillin allergy.

Spike Mafford/Thinkstock

Although 10%-20% of patients report a penicillin allergy, “[a] majority of patients who report PCN [penicillin] allergy are not truly allergic upon confirmatory testing,” Dr. Mattingly and his colleagues wrote.

This overreporting of penicillin allergies is a problem for the patient and the health care system because “reported antibiotic allergies have been associated with suboptimal antibiotic therapy, increased antimicrobial resistance, increased length of stay, increased antibiotic-related adverse events, increased rates of C. difficile infection, intensive care unit (ICU) admission, death, as well as increased treatment cost,” said Dr. Mattingly and his coauthors.

Pages

Recommended Reading

Potential postthyroidectomy quality improvement metrics arise from study
MDedge Surgery
Gastrointestinal complications are a key risk factor for death after AEF repair
MDedge Surgery
MSQC quality recommendations improve SSI in colectomy patients
MDedge Surgery
Clinical Trial: The Checklist to Prevent MRSA Surgical Site Infections
MDedge Surgery
Predicting MDR Gram-negative infection mortality risk
MDedge Surgery